Status:
RECRUITING
COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)
Lead Sponsor:
Odense University Hospital
Conditions:
Cardiac Toxicity
Lung Cancer Stage III
Eligibility:
All Genders
18+ years
Brief Summary
Patients with loco-regional NSCLC planned for curative treatment with chemoradiotherapy will be invited to participate in a prospective study; besides routine treatment, the patients will be followed ...
Detailed Description
Definitive chemo-radiotherapy is the treatment of choice for loco-regional advanced non-small cell lung cancer (LA-NSCLC). However, the treatment is associated with a range of side effects with radiat...
Eligibility Criteria
Inclusion
- Age ≥ 18 Years
- Inoperable and histologically/cytologically verified NSCLC.
- Planned treatment with curative intent.
- Capable of completing study procedures ECG and Cardiac MR.
- Able of giving written and informed consent before study procedures are initiated.
Exclusion
- Vulnerable patients.
- Patients with operable devices as pacemaker/ICD and cochlear implant or other conditions where MR scan is contraindicated.
- Claustrophobia.
Key Trial Info
Start Date :
August 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05258448
Start Date
August 1 2015
End Date
October 1 2026
Last Update
December 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Odense University Hospital
Odense C, Denmark, 5000